Fluorescence in situ hybridization in infectious disease diagnostics: from analytic positivity to tissue causality and clinical actionability

Culture-negative infections and biofilm-associated disease challenge diagnostic methods that identify microbial material without preserving its location. We critically reviewed fluorescence in situ hybridization (FISH), peptide nucleic acid FISH (PNA-FISH), combined FISH and 16S rRNA-gene sequencing (FISHseq), and selected multiplex variants across clinical specimen matrices. This narrative review uses targeted literature searching and study-level evidence mapping; it does not claim systematic-review completeness or pooled diagnostic accuracy. Defined probes can expedite identification from growth-positive blood cultures, whereas direct FISH has limited value as a first-line test for microscopy-negative cerebrospinal fluid. In selected surgical heart-valve series, FISHseq increased reported organism identification relative to valve culture, although imperfect reference standards, selected populations and discrepancies in reported data limit interpretation. Vaginal, urinary, implant-associated and oral/intestinal studies show spatial insights but heterogeneous degrees of clinical validation. Results depend on probe design, biomass, processing, tissue matrix and panel coverage; an rRNA-FISH signal neither establishes viability nor proves etiologic causality. We propose Analytic Positivity → Etiologic Plausibility → Clinical Actionability (AP → EP → CA) as an interpretive aid that also accommodates polymicrobial communities and indeterminate findings. The framework is not externally clinically validated. FISH is best positioned as a matrix-specific adjunct, with predefined quality control, orthogonal testing and clinically meaningful implementation criteria rather than as a universal alternative to culture, nucleic-acid amplification or sequencing.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2026-11-17
DOI
https://doi.org/10.3389/fmicb.2026.1929962
Primary Topic
Bacterial Identification and Susceptibility Testing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fluorescence in situ hybridization in infectious disease diagnostics: from analytic positivity to tissue causality and clinical actionability

Maksim O. Antipov, Oleg V. Mitrokhin, Ekaterina Shashina, T.S. Isiutina-Fedotkova et al.
Frontiers in Microbiology
Bacterial Identification and Susceptibility Testing
article

Fluorescence in situ hybridization in infectious disease diagnostics: from analytic positivity to tissue causality and clinical actionability

Maksim O. Antipov, Oleg V. Mitrokhin, Ekaterina Shashina, T.S. Isiutina-Fedotkova, Нестеров Георгий Владимирович, Denis V. Shcherbakov, Вероника Рамилевна Сайфутдинова, Басов Артём Александрович, Olga D. Matsaeva, Nina I. Starovoitova
article en

Abstract

Culture-negative infections and biofilm-associated disease challenge diagnostic methods that identify microbial material without preserving its location. We critically reviewed fluorescence in situ hybridization (FISH), peptide nucleic acid FISH (PNA-FISH), combined FISH and 16S rRNA-gene sequencing (FISHseq), and selected multiplex variants across clinical specimen matrices. This narrative review uses targeted literature searching and study-level evidence mapping; it does not claim systematic-review completeness or pooled diagnostic accuracy. Defined probes can expedite identification from growth-positive blood cultures, whereas direct FISH has limited value as a first-line test for microscopy-negative cerebrospinal fluid. In selected surgical heart-valve series, FISHseq increased reported organism identification relative to valve culture, although imperfect reference standards, selected populations and discrepancies in reported data limit interpretation. Vaginal, urinary, implant-associated and oral/intestinal studies show spatial insights but heterogeneous degrees of clinical validation. Results depend on probe design, biomass, processing, tissue matrix and panel coverage; an rRNA-FISH signal neither establishes viability nor proves etiologic causality. We propose Analytic Positivity → Etiologic Plausibility → Clinical Actionability (AP → EP → CA) as an interpretive aid that also accommodates polymicrobial communities and indeterminate findings. The framework is not externally clinically validated. FISH is best positioned as a matrix-specific adjunct, with predefined quality control, orthogonal testing and clinically meaningful implementation criteria rather than as a universal alternative to culture, nucleic-acid amplification or sequencing.

Frontiers in MicrobiologyVol. 17
Sechenov University (RU)
Good health and well-being
Bacterial Identification and Susceptibility Testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon